Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Comparative efficacy and acceptability of treatments for restless legs syndrome in end-stage renal disease: a systematic review and network meta-analysis.

Huang CW, Lee MJ, Wang LJ, Lee PT, Tu YK, Hsu CW, Lin PY.

Nephrol Dial Transplant. 2019 Jun 3. pii: gfz097. doi: 10.1093/ndt/gfz097. [Epub ahead of print]

PMID:
31157898
2.

Interventions for chronic kidney disease-associated restless legs syndrome.

Gopaluni S, Sherif M, Ahmadouk NA.

Cochrane Database Syst Rev. 2016 Nov 7;11:CD010690. Review.

3.

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Sbidian E, Chaimani A, Garcia-Doval I, Do G, Hua C, Mazaud C, Droitcourt C, Hughes C, Ingram JR, Naldi L, Chosidow O, Le Cleach L.

Cochrane Database Syst Rev. 2017 Dec 22;12:CD011535. doi: 10.1002/14651858.CD011535.pub2. Review.

4.

What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.

Hornyak M, Scholz H, Kohnen R, Bengel J, Kassubek J, Trenkwalder C.

Sleep Med Rev. 2014 Apr;18(2):153-64. doi: 10.1016/j.smrv.2013.03.004. Epub 2013 Jun 6. Erratum in: Sleep Med Rev. 2014 Aug;18(4):367-8.

PMID:
23746768
5.

Treatment for Restless Legs Syndrome [Internet].

Wilt TJ, MacDonald R, Ouellette J, Tacklind J, Khawaja I, Rutks I, Butler M, Fink HA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov.

6.

Dopamine agonists for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD006009. doi: 10.1002/14651858.CD006009.pub2. Review.

PMID:
21412893
7.

Effect of non-ergot dopamine agonists on health-related quality of life of patients with restless legs syndrome.

Talati R, Phung OJ, Mather J, Coleman CI.

Ann Pharmacother. 2009 May;43(5):813-21. doi: 10.1345/aph.1L673. Epub 2009 Apr 28.

PMID:
19401472
8.

Pharmacological interventions for somatoform disorders in adults.

Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ.

Cochrane Database Syst Rev. 2014 Nov 7;(11):CD010628. doi: 10.1002/14651858.CD010628.pub2. Review.

PMID:
25379990
9.

Levodopa for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005504. doi: 10.1002/14651858.CD005504.pub2. Review.

PMID:
21328278
10.

Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial.

Dauvilliers Y, Benes H, Partinen M, Rauta V, Rifkin D, Dohin E, Goldammer N, Schollmayer E, Schröder H, Winkelman JW.

Am J Kidney Dis. 2016 Sep;68(3):434-43. doi: 10.1053/j.ajkd.2015.12.027. Epub 2016 Feb 3.

PMID:
26851201
11.

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.

Tramacere I, Del Giovane C, Salanti G, D'Amico R, Filippini G.

Cochrane Database Syst Rev. 2015 Sep 18;(9):CD011381. doi: 10.1002/14651858.CD011381.pub2. Review.

PMID:
26384035
12.
13.

Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis.

Wilt TJ, MacDonald R, Ouellette J, Khawaja IS, Rutks I, Butler M, Fink HA.

JAMA Intern Med. 2013 Apr 8;173(7):496-505. doi: 10.1001/jamainternmed.2013.3733. Review.

PMID:
23460396
14.

Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials.

Zhang W, Wang Y, Cong SY, Nao JF, Feng J, Bi GR.

Neuropsychiatr Dis Treat. 2013;9:1035-43. doi: 10.2147/NDT.S49454. Epub 2013 Jul 30.

15.

Restless legs syndrome is associated with cardio/cerebrovascular events and mortality in end-stage renal disease.

Lin CH, Sy HN, Chang HW, Liou HH, Lin CY, Wu VC, Wu SL, Chang CC, Chiu PF, Li WY, Lin SY, Wu KD, Chen YM, Wu RM.

Eur J Neurol. 2015 Jan;22(1):142-9. doi: 10.1111/ene.12545. Epub 2014 Aug 21.

PMID:
25142748
16.

E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions.

Thabrew H, Stasiak K, Hetrick SE, Wong S, Huss JH, Merry SN.

Cochrane Database Syst Rev. 2018 Aug 15;8:CD012489. doi: 10.1002/14651858.CD012489.pub2. Review.

PMID:
30110718
17.

Comparative Efficacy and Acceptability of Pharmacological, Psychotherapeutic, and Combination Treatments in Adults With Posttraumatic Stress Disorder: A Network Meta-analysis.

Merz J, Schwarzer G, Gerger H.

JAMA Psychiatry. 2019 Jun 12. doi: 10.1001/jamapsychiatry.2019.0951. [Epub ahead of print]

PMID:
31188399
18.

Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Liu GJ, Wu L, Lin Wang S, Xu LL, Ying Chang L, Fu Wang Y.

Clin Ther. 2016 Jan 1;38(1):162-179.e6. doi: 10.1016/j.clinthera.2015.10.010. Epub 2015 Nov 11. Review.

19.

Opioids for restless legs syndrome.

de Oliveira CO, Carvalho LB, Carlos K, Conti C, de Oliveira MM, Prado LB, Prado GF.

Cochrane Database Syst Rev. 2016 Jun 29;(6):CD006941. doi: 10.1002/14651858.CD006941.pub2. Review.

PMID:
27355187
20.

Effects of Exercise Training on Restless Legs Syndrome, Depression, Sleep Quality, and Fatigue Among Hemodialysis Patients: A Systematic Review and Meta-analysis.

Song YY, Hu RJ, Diao YS, Chen L, Jiang XL.

J Pain Symptom Manage. 2018 Apr;55(4):1184-1195. doi: 10.1016/j.jpainsymman.2017.12.472. Epub 2017 Dec 14.

PMID:
29247753

Supplemental Content

Support Center